A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how to design a vaccine ...

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

Repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes already bound to the virus ...

Researchers at the Max Planck Institute of Biophysics and Heidelberg University have observed largely intact HIV-1 capsids as ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will ...

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...

HMPV causes flu-like symptoms. The virus usually affects the upper respiratory system but can sometimes cause lower respiratory infections. HMPV is more common in winter and early spring.

The future may be getting brighter in terms of reducing the threat of the human immunodeficiency virus (HIV), infectious disease experts told Newsweek. With new treatments and maybe even a vaccine ...

News reports and social media posts are warning of a new outbreak of a little-known virus called human metapneumovirus (HMPV) in China, but officials are yet to confirm this. Instead, official ...